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Abstract
Aims. To examine the factors that are associated with changes in depression in people with
type 2 diabetes living in 12 different countries.
Methods. People with type 2 diabetes treated in out-patient settings aged 18–65 years underwent
a psychiatric assessment to diagnose major depressive disorder (MDD) at baseline and follow-up.
At both time points, participants completed the Patient Health Questionnaire (PHQ-9), the
WHO five-item Well-being scale (WHO-5) and the Problem Areas in Diabetes (PAID) scale
which measures diabetes-related distress. A composite stress score (CSS) (the occurrence of
stressful life events and their reported degree of ‘upset’) between baseline and follow-up was cal-
culated. Demographic data and medical record information were collected. Separate regression
analyses were conducted with MDD and PHQ-9 scores as the dependent variables.
Results. In total, there were 7.4% (120) incident cases of MDD with 81.5% (1317) continuing to
remain free of a diagnosis of MDD. Univariate analyses demonstrated that those with MDD were
more likely to be female, less likely to be physically active, more likely to have diabetes complications
at baseline andhave higherCSS.Mean scores for theWHO-5, PAIDandPHQ-9were poorer in those
with incidentMDDcomparedwith thosewhohadneverhadadiagnosisofMDD.Regressionanalyses
demonstrated that higher PHQ-9, lowerWHO-5 scores and greater CSSwere significant predictors of
incidentMDD. Significant predictors of PHQ-9were baseline PHQ-9 score,WHO-5, PAIDandCSS.
Conclusion. This study demonstrates the importance of psychosocial factors in addition to physio-
logical variables in the development of depressive symptoms and incidentMDD in peoplewith type
2 diabetes. Stressful life events, depressive symptoms and diabetes-related distress all play a signifi-
cant rolewhich has implications for practice. Amore holistic approach to care, which recognises the
interplay of these psychosocial factors, may help to mitigate their impact on diabetes self-manage-
ment as well as MDD, thus early screening and treatment for symptoms is recommended.
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Introduction
It is now well-known that the prevalence of both diabetes and
mental health problems is increasing rapidly, with a greater risk
for depression in people with diabetes compared to those without
(Nouwen, 2010; 2015; Lloyd et al., 2012; Roy and Lloyd, 2012;
Mommersteeg et al., 2013; Salinero-Fort et al., 2018). Comorbid
diabetes and depression are linked to increased mortality as well
as a greater risk for developing other conditions including heart
and kidney disease (Reeves et al., 2015; Novak et al., 2016;
Naicker et al., 2017; Nouwen et al., 2019). In addition, the com-
bination of diabetes and depression has a far greater impact on
well-being compared with depression and other comorbid dis-
eases (Moussavi et al., 2007). There is evidence that depression
can be treated successfully with both psychological and pharma-
cological interventions in people with diabetes (van der
Feltz-Cornelis et al., 2010; Nicolau et al., 2013); however, more
research is required to clarify which factors predict the onset of
this condition. In addition, there are extra challenges given that
emotional distress may be present in people with diabetes due
to difficulties with the sometimes overwhelming requirements
of self-management which can, in turn, impact on and be influ-
enced by depression (van der Feltz-Cornelis et al., 2010;
Baumeister et al., 2012; Petrak et al., 2015). Indeed, our own
research has demonstrated that both elevated levels of diabetes-
related emotional distress and a history of depression were inde-
pendently associated with major depressive disorder (MDD)
(Lloyd et al., 2015; Lloyd et al., 2018). A systematic review has
suggested that diabetes distress can be reduced with tailored inter-
ventions (Schmidt et al., 2018), although it may be difficult to dis-
entangle diabetes distress from depressive symptoms (Snoek et al.,
2015). Longitudinal studies investigating risk factors for the inci-
dence of clinically diagnosed depression in people with diabetes
are few and far between; this paper reports the follow-up results
from the INTERPRET-DD study which now has data collected
in 12 countries (Lloyd et al., 2015); a study that is unique as it
includes both a clinical diagnosis of depression and depressive
symptoms as well as a measure of diabetes-related emotional dis-
tress, carried out in countries with vast differences in culture and
health systems. We aimed to identify specific risk factors for the
onset of diagnosed depression as well as depressive symptoms
in this cohort of individuals with type 2 diabetes.
This study was initiated within the framework of the Dialogue
on Diabetes and Depression (http://diabetesanddepression.org/),
an international alliance of associations and organisations and
continued under the auspices of the Association for the
Improvement of Mental Health Programmes, a non-governmental
organisation in Geneva engaged in educational and other pro-
grammes dealing with the comorbidity of mental and physical dis-
orders (Sartorius and Cimino, 2012).
Materials and methods
A full description of our protocol is provided in our earlier papers
(Lloyd et al., 2015; Lloyd et al., 2018). In brief, between September
2013 and May 2015, a sample of consecutive out-patient clinic
attenders with type 2 diabetes at each of the study sites was invited
to participate in the study, with the aim of including 200 people
with type 2 diabetes in each country. The teams of investigators in
the collaborating sites (recruited from leading centres of excel-
lence in their country) included at least one psychiatrist and
one endocrinologist in each country. The treating physician or
diabetologist in the diabetes clinic invited individuals to partici-
pate in the study. Diabetes clinics were based in either secondary
or tertiary care centres, depending on the facilities available in
each country. Written informed consent was obtained for partici-
pation in both the baseline and follow-up data collections.
Inclusion/exclusion criteria
Eligible study participants were adults (18–65 years of age) with
type 2 diabetes diagnosed at least 12 months before the point of
contact attending their diabetes out-patient facilities. Individuals
were excluded if they had been diagnosed with type 2 diabetes
for less than 12 months as it is usual to experience a period of
adjustment when first diagnosed. Other exclusion criteria were a
diagnosis of type 1 diabetes, being unable to complete the survey
tools due to communication or cognitive difficulties or having any
life-threatening or serious conditions (e.g. cancer, stroke in the
last 6 months). Those currently admitted or planning an admis-
sion for in-patient care to a hospital (unless admitted for diabetes
self-management) were excluded as this group may have been
receiving more intensive or different treatment for their diabetes
and so were less comparable to those not admitted. Women
who were pregnant/had had a child in the last 6 months were
also excluded, as were those who had received a clinical diagnosis
of dependency on alcohol or other substance (not tobacco) or a
diagnosis of schizophrenia.
Prior to interview, the site investigators completed an informa-
tion form for each eligible individual. This form included infor-
mation from medical records, such as age, duration of diabetes,
family history of diabetes and presence/history of diabetes com-
plications. The latter included cardiovascular disease, retinopathy,
peripheral neuropathy, peripheral vascular disease and renal dis-
ease and associated disorders. Most recent measurements of blood
pressure, height and weight were also recorded. A diagnosis of
Major Depressive Disorder (MDD) was made at interview so
that the proximity of clinical records did not differ. Participants
were asked if they lived in what they considered to be a rural or
an urban area and reported their highest level of education
(defined as no formal, some/completed primary, some/completed
secondary school, or higher education which was defined as any
college, post-graduate or professional training). Marital status
was defined as married/cohabiting v. being single/widowed/
divorced which, for our analyses, was dichotomised into living
alone v. not living alone. Participants were also asked if they con-
sidered that they had a regular income.
Each participant was asked to complete the Patient Health
Questionnaire (PHQ-9), the WHO-5 Well-being questionnaire
and the Problem Areas in Diabetes Scale (PAID). The PHQ-9
consists of nine items on a four-point Likert-type scale
(Kroenke and Spitzer, 2001). It has good sensitivity and specificity
with regard to identifying cases of depression as well as being sen-
sitive to change over time, and it has been used in a number of
different countries (Kroenke and Spitzer, 2001). The WHO-5 is
a five-item scale measuring feelings of well-being (World Health
Organization, regional office for Europe, 1998). Unlike other
scales, it identifies on a six-point scale the absence of positive feel-
ings rather than the presence of negative ones (World Health
Organization, regional office for Europe, 1998). The PAID is a
20-item questionnaire which measures the extent of diabetes-
related emotional distress (Polonsky et al., 1995). Items include
‘feeling overwhelmed with your diabetes’ and ‘feelings of guilt
or anxiety when you get off track with your diabetes
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management’. Moderate–severe levels of diabetes-related distress
are defined as scores (standardised to 100) >40 (Polonsky et al.,
1995). All questionnaires were completed using standard self-
complete methods in the appropriate language, or assisted
one-to-one collection, with the questions read out by the
researcher and answered by the participant. Where no existing
translation/cultural adaption of the questionnaires were avail-
able, they were adapted using standard forward/back translation
procedures. In addition, each country’s investigators ensured
they were culturally applicable through their development
over several iterative stages involving discussion and testing
with a range of health care professionals and people with type
2 diabetes, focusing on the meaning of terms as well as
language.
In order to diagnose MDD, a psychiatric interview was subse-
quently conducted by a trained interviewer using the MINI
International Neuropsychiatric Interview (MINI; V5 or V6
depending on current psychiatric practice at the study site)
(Sheehan et al., 1998). The MINI has been widely used in a
range of different populations – including those with serious ill-
nesses and in community surveys and is a reliable tool indicating
the diagnostic category according to DSM-5 criteria (American
Psychiatric Association, 2013). Individuals diagnosed with
MDD (or other psychiatric disorders such as anxiety disorders)
were advised to consult their physician for further assessment
and treatment. If any individual indicated suicidality (question
9 on the PHQ-9), the psychiatrist conducting the clinical inter-
view initiated immediate appropriate care.
After a minimum of 12 months, baseline respondents were
contacted to participate a second time. The same instruments
were used with the addition of the Holmes and Rahe Perceived
Social Readjustment (HRPSR) Scale (Holmes and Rahe, 1967).
The HRPSR measures stress in terms of life events that are
hypothesised to increase the risk of illness (Holmes and Rahe,
1967). Individual scores for life events are weighted according
to the perceived level of stress each one might engender. An add-
itional measure was added to account for the degree of upset
experienced if an event had occurred, measured on a four-point
scale from 0 (not at all) to 3 (very much). This scale was added
because the original HRPSR scale assumes that the felt impact
of an event is similar regardless of context; our addition of the
upset scale gave us a deeper insight into the experience of an
event within the individual’s overall life context. A composite
stress score (CSS) was created that combined the experienced
stressful events during the follow-up period with how much
they upset the person, calculated as the product of occurrence
and affect scores. Two additional items, ‘civil unrest’ and ‘phys-
ical, sexual, or emotional abuse’, were added to the life event
list. A final unspecified item was added to allow for major life
events that were not on the list to be recorded.
Change in MDD status between baseline and follow-up data
collection was defined as (1) no MDD at either baseline or
follow-up (or during the 3 years prior to baseline, or any time
between baseline and follow-up), (2) MDD diagnosed at both
baseline (or during the 3 previous years) and follow-up, (3) inci-
dent MDD, i.e. the participant reported at least one episode of
depression between baseline and follow-up and no depression at
baseline or during the previous 3 years, and (4) remission of
depression, i.e. MDD diagnosed at baseline or up to 3 years
prior and no depression between baseline and follow-up inter-
view. The data reported here pertain only to those who fully par-
ticipated and who therefore had complete information on
socio-demographics, clinical and psychological status at both
time points (n = 1616).
Ethical approval
All procedures were approved by the ethics committees in each
study setting, complied with the ethical standards of the relevant
national and institutional committees on human experimentation
and with the Helsinki Declaration of 1975 as revised in 2008, and
included participation at both baseline and follow-up data collec-
tion. In addition, ethical approval was obtained from the Human
Research Ethics Committee at The Open University, UK, where
the data were stored for analysis.
Statistical analysis
SPSS version 23 (Hosmer and Lemeshow, 2000) was used to ana-
lyse the data. For this analysis, we only selected those participants
for whom we had data at both baseline and follow-up points and
compared those with incident MDD to those with no MDD at
either baseline or follow-up.
In order to examine the predictors of incident MDD during
the follow-up period, we first carried out univariate analyses on
the following baseline variables: country, marital status (living
with someone v. living alone), level of education, income, location
(urban v. rural area), insulin status, smoking status, exercise, sex,
baseline complications, BMI, diabetes duration, age, WHO-5,
PAID, PHQ-9, CSS as well as follow-up duration. The statistically
significant ( p < 0.05) variables were then entered into a bivariate
logistic regression. The outcome variable was onset of MDD (no
MDD at baseline and a diagnosis of MDD at follow-up) with the
predictor variables being insulin, exercise, sex, baseline complica-
tions, age, WHO-5, PAID, PHQ-9 and the CSS. In step 1, we
adjusted for country, and in step 2, we added the remaining vari-
ables with a forward step selection method.
In order to investigate whether self-report of depressive symp-
toms would yield similar predictors as the diagnosis of depression,
a linear regression was carried out, using follow-up PHQ-9 score
as the outcome variable and controlling for country in step 1, fol-
lowed by a forward selection method for the predictor variables
above in step 2.
Results
A total of 1616 participants had known MDD status at both
baseline and follow-up. Participation rates differed significantly
by country ranging from 55.6% in India to 98.5% in Ukraine,
and level of education (no formal education v. primary, second-
ary, higher education; 6.4 v. 10.0, 19.2 v. 22.0, 33.4 v. 10.4
and 29.5 v. 27.7%; p < 0.01). Individuals on insulin were more
likely to participate in the follow-up data collection compared
with those not on insulin (77.6 v. 72.0%; p < 0.01). Smokers
were more likely to participate than non-smokers (81.0 v.
73.2%; p < 0.01). Diabetes distress scores were higher in partici-
pants compared to non-participants (17.9 ± 18.4 v. 16.1 ± 18.3;
Mann–Whitney test p < 0.05), and the number of complications
was higher in participants than non-participants (1.05 ± 1.38 v.
0.81 ± 1.04; p < 0.001); however, PHQ-9 scores did not differ sig-
nificantly between those who participated in the follow-up and
those who did not.
Table 1 shows the MDD status of all those with a psychiatric
assessment at both baseline and follow-up with 120 (7.4%)
Epidemiology and Psychiatric Sciences 3
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incident MDD cases and 1317 (81.5%) continuing to remain free
of a diagnosis of MDD. A surprisingly high rate of incident MDD
was apparent in the Ukraine sample, whereas there were no new
cases of MDD in the Ugandan sample. Very low incident rates
were observed in the Russian, Polish and Kenyan participants.
Univariate analyses comparing those who did not develop
MDD with those who did (Table 2) found that the mean length
of follow-up was the same; however, they were more likely to be
female and taking insulin for their diabetes (Table 2). They
were also less likely to have reported regularly taking part in phys-
ical activity and were more likely to have diabetes complications at
baseline. Mean age in this latter group was somewhat lower than
those who did not develop depression. Mean scores for the
WHO-5, PAID and PHQ-9 were poorer in those with incident
MDD or who had received a diagnosis of MDD at both time
points compared with those who had never had a diagnosis of
MDD. In addition, CSS were significantly higher in those with
incident MDD compared to the other group (Table 2).
A binary logistic regression analysis using remained non-
depressed (i.e. no diagnosis at either time points) v. incident
MDD as the binary outcome variable demonstrated that, after
adjusting for country of study, higher PHQ-9 and lower
WHO-5 scores at baseline and higher CSS during the follow-up
period were all significant predictors of incident MDD (see
Table 3).
A similar analysis using follow-up PHQ-9 score as the out-
come variable found that, after adjusting for country (and exclud-
ing baseline PHQ-9 score from the analysis), WHO-5, PAID, CSS,
sex and insulin treatment were significant predictors (Table 4).
When baseline PHQ-9 score was added to the model (Table 5),
the effect of sex and insulin was no longer significant.
Therefore, in addition to explaining more of the variance
(Adjusted R2 = 0.495 v. 0.419), the latter model was more parsi-
monious. Since heteroscedasticity was confirmed in the raw
data, which tends for the model to underestimate p-values, a log-
transformation was carried out. Results confirmed the signifi-
cance of predictors above, with sex re-entering the model.
PAID scores at both baseline and follow-up were significantly
correlated with CSS (R2 = 0.374 and 0.512; p = 0.01, respectively).
PAID and CSS did not significantly differ according to sex.
Figure 1 shows the mean CSS for those who remained non-
depressed and those with incident MDD by country.
Overall, the highest CSS were ‘death of a close family mem-
ber’, ‘change in financial state’, ‘major change in the health of a
family member’, ‘major personal injury or illness’, ‘change in
sleeping habits’ and ‘change in eating habits’. Mexico reported
the highest CSS for ‘major personal injury or death’, with
Ukraine participants reporting the highest scores for ‘change
in sleeping habits’ and ‘major change in the health of a family
member’. Table 6 provides an overview of the most important
stressors by country.
The events rated as most upsetting were ‘death of a spouse’,
‘physical, sexual, or emotional abuse’, ‘divorce’, ‘marital separ-
ation’, ‘other life event/stressor not specified elsewhere’, ‘fired at
work’ and ‘detention in jail or other institution’. The events
rated the least upsetting were ‘marriage’, ‘religious holiday’, ‘vac-
ation’, ‘outstanding personal achievement’, ‘pregnancy’ and ‘gain
of a new family member’.
Discussion
This study has demonstrated the importance of psychosocial fac-
tors as risk factors for the onset of MDD and increased depressive
symptoms. The World Health Organisation has identified the
treatment of depression and other mental health problems as a
priority for the 21st century; however, only a few studies have
identified the risk factors that are associated with the development
of mental health problems, in particular in people with
Table 1. Country data for those with depression status known at both baseline and follow-up
Country (N )
Males N
(%)
Age Mean
(S.D.)
Diabetes duration
Mean (S.D.)
No MDD diagnosis within the time
points (No–No) N (%)
Incident depression (No–
Yes) N (%)
Argentina
(77)
41 (53.2) 57.1 (8.02) 10.6 (6.9) 64 (83.1) 5 (6.5)
Germany
(83)
51 (61.4) 54.4 (7.3) 7.0 (7.8) 72 (86.7) 6 (7.2)
India (105) 57 (54.3) 52.8 (9.7) 8.2 (5.8) 92 (87.6) 10 (9.5)
Italy (161) 94 (58.4) 56.8 (6.8) 10.0 (7.8) 138 (85.7) 8 (5.0)
Kenya (148) 32 (21.6) 50.0 (11.7) 7.2 (6.0) 131 (88.5) 5 (3.4)
Mexico (165) 63 (38.2) 52.4 (8.5) 11.1 (7.5) 127 (77.0) 9 (5.5)
Pakistan
(148)
66 (44.6) 51.4 (9.0) 8.4 (6.0) 122 (82.4) 16 (10.8)
Poland (143) 74 (51.7) 57.6 (7.5) 10.0 (7.4) 109 (76.2) 5 (3.5)
Russia (151) 33 (21.9) 56.5 (7.7) 8.7 (6.2) 116 (76.8) 3 (2.0)
Serbia (187) 82 (43.9) 58.5 (5.7) 9.3 (5.8) 155 (82.9) 7 (3.7)
Uganda
(118)
40 (33.9) 50.7 (8.2) 6.7 (5.3) 118 (100.0) 0 (0.0)
Ukraine
(130)
58 (44.6) 46.6 (11.9) 8.9 (6.6) 73 (56.2) 46 (35.4)
Total (1616) 691 (42.8) 53.8 (9.3) 8.9 (6.7) 1317 (81.5) 120 (7.4)
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co-occurring conditions such as diabetes. Exceptions to this
include studies in the Netherlands and the USA (Naranjo et al.,
2011; Nefs et al., 2012; Johnson et al., 2014), with Nefs et al. iden-
tifying stressful life events (although only measured by a single
item), diabetes complications and a previous history of depression
as risk factors for subsequent depression (Nefs et al., 2012).
Although our incident rate for MDD was slightly lower than
the Netherlands study, this may be due to a different measure-
ment tool and lack of a clinical interview to diagnose depression
in that study. We have observed differences in the incidence of
MDD according to country and there are a number of factors
Table 2. Univariate analyses of predictors of incident MDD
Nominal variables, χ2, one-sided* test for significance
Remained not depressed (N = 1317) N (%) Incident MDD (N = 120) N (%) p-value
Male 595 (45.1) 42 (35.3) 0.024
On insulin 511 (38.7) 68 (57.1) <0.001
Regular exercise 773 (59.1) 49 (41.2) <0.001
Married/cohabiting 938 (71.1) 78 (65.5) 0.121
Regular income 1108 (84.0) 93 (78.2) 0.068
Formal education
None 84 (6.4) 13 (10.9)
Primary school 252 (19.1) 27 (22.7)
Secondary school 590 (44.7) 43 (36.1)
Higher education 393 (29.8) 36 (30.3) 0.058
Urban location 1108 (84.0) 106 (89.1) 0.088
Smokers 196 (14.9) 19 (16.0) 0.415
Linear variables, ANOVA, one-sided test for significance
Remained not depressed Mean (S.D.) Incident MDD Mean (S.D.) p-value
Age 53.8 (9.5) 51.6 (9.6) 0.015
Diabetes duration 8.7 (6.7) 9.9 (7.5) 0.122
WHO-5 score 17.7 (4.9) 12.6 (5.4) <0.001
Total PAID score 14.7 (16.0) 29.5 (18.4) <0.001
PHQ-9 score 3.6 (3.5) 9.1 (4.7) <0.001
Composite stress score 10.0 (13.4) 29.8 (21.6) <0.001
Number of complications 0.9 (1.3) 1.9 (1.8) <0.001
Body mass index 29.5 (6.1) 29.8 (5.7) 0.623
Follow-up time (months) 14.0 (2.4) 13.7 (1.9) 0.130
*One-sided significance levels were used because previous research has shown these factors to be implicated in the development and maintenance of depression.
Table 3. Significant predictors of incident depression diagnosis (MDD) in
bivariate logistic regression, adjusted for country
Predictor OR 95% CI p-value
Baseline PHQ-9 score 1.23 1.15–1.31 <0.001
WHO-5 score 0.92 0.87–0.98 0.01
Composite stress score 1.06 1.04–1.09 <0.001
Outcome variable: depression (MDD) status at follow-up (no depression v. incident MDD).
N = 1364. Nagelkerke’s R2 = 0.438. Non-significant factors: diabetes complications, PAID, sex,
insulin, age, exercise.
Table 4. Significant predictors of follow-up PHQ-9 scores in linear regression,
adjusted for country (baseline PHQ-9 scores not entered as predictor variables)
Predictor Standardised coefficient p-value
WHO-5 score −0.29 <0.001
PAID score 0.22 <0.001
Composite stress score 0.30 <0.001
Sex 0.05 0.011
Insulin 0.04 0.047
N = 1542. Adjusted R2 = 0.419. Non-significant factors: diabetes complications, PAID, age,
physical activity.
Table 5. Significant predictors of follow-up PHQ-9 scores in linear regression,
adjusted for country and including baseline PHQ-9 scores
Predictor Standardised coefficient p-value
Baseline PHQ-9 score 0.43 <0.001
Composite stress score 0.25 <0.001
PAID score 0.10 <0.001
WHO-5 score −0.06 0.038
N = 1531. Adjusted R2 = 0.495. Non-significant factors: sex, insulin, age, complications,
physical activity.
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that may explain this. First, there are differences in psychosocial
conditions, the clinical manifestation of depression and the nature
of care provided in different countries. Second, the different gen-
der and age composition of patients by country (particularly in
Russia) could play a meaningful role.
The role of stress
Although it is known that there is a link between diabetes and
depression, the role of stress is less clear possibly due to differences
in its measurement (Joseph and Golden, 2017). A few studies have
reported a link between stress and diabetes self-management
(Smith et al., 2020), but the impact of stressors not only in relation
to diabetes but as part of the individual’s broader experience has
been less examined. A caveat to this has been the work proposing
the concept of ‘syndemics’ which points to a complexity of factors
that increase the risk of poor health (Mendenhall et al., 2015).
Mendenhall et al. have observed that the prevalence of diabetes var-
ies in different socio-economic groups, with co-existing stress and
struggles living with diabetes greater in the poorest individuals.
Acknowledging the cumulative effect of life stress and managing
diabetes on mental health can provide a more holistic picture of
the individual which has important implications for practice
(Fisher et al., 2001).
Our adaptation of the Holmes and Rahe scale to include a
measure of ‘upset’ has meant that we are able to measure stress
in a way that is more likely to represent the actual perceived
impact of events within the context of peoples’ lives. Our meas-
ure does not make any assumptions as to the severity of an
event, but rather it is based on the individual’s perception
once it occurs. In addition, we added specific events that were
more culturally relevant to each country (as identified by the
country-specific investigative team), to make our data more cul-
turally relevant and country-specific. At the same time, we can
identify the most common stressors, some of which challenge
our ideas as to what are the most stressful events, such as a
change in eating or sleeping habits. These latter events could
be related to the physiological aspects of diabetes as well as to
depression, especially given the strong correlation between
stress and diabetes distress in our study. Our adapted scale
could be a useful instrument to screen for vulnerability to
depression in future studies.
Cultural factors and risk of depression among people with type
2 diabetes
Culturally specific concerns with regard to variations in reporting
depressive symptoms have been suggested (Kirmayer et al., 2017)
and culturally adapted measurement instruments recommended
(Tarricone et al., 2012). We have been able to mitigate this by
ensuring that we utilised country-specific translations/interpreta-
tions for both the PHQ-9 and the MINI and that trained psychia-
trists were from the same country/region and were able to ensure
that the questions were asked in an appropriate way. A further
strength of our study is the use of both a symptom scale and a
diagnostic interview to determine the presence/absence of depres-
sive symptoms/MDD.
Our finding that baseline PHQ-9 scores were significantly
associated with incident MDD as well as depressive symptoms
supports previous work on the association between these two
measures, although unlike our prospective study in 12 countries,
most research has been cross-sectional in single countries
(Darwish et al., 2018). Recognition of depressive symptoms as a
precursor to clinical levels of depression could lead to earlier
interventions that reduce the risk of MDD. Although PAID
(diabetes distress) scores were not found to be an independent
predictor of MDD, our multivariable analysis found it to be a fur-
ther important predictor of depressive symptomatology (PHQ-9).
This is unsurprising, given their known association; however, it
provides another potential avenue for the identification of those
at risk of depression easily determined during clinical encounters
(Schmitz et al., 2014; Darwish et al., 2018).
A limitation of our study is that only those who had complete
data could be included in our analyses and were more likely to
have complications, treated with insulin, smoke and have higher
diabetes distress scores (although baseline PHQ-9 scores did not
differ significantly). These individuals may have been more likely
to return to their diabetes centre for care and so were more likely
to have been available for follow-up recruitment.
Our findings have implications for clinical practice and the
possibilities for reducing the risk of depression. The high (and
increasing) prevalence of type 2 diabetes may induce healthcare
providers to standardise the clinical management of this condi-
tion, in order to reduce professionals’ time expenditure and bur-
den to a minimum. Our data show that a more holistic approach,
including a discussion of life events, may help to identify
Fig. 1. Composite stress scores by depression status
for each country (for participants with a completed
Holmes and Rahe).
6 C. E. Lloyd et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S2045796020000438
Downloaded from https://www.cambridge.org/core. IP address: 151.227.80.105, on 11 Jun 2020 at 10:39:19, subject to the Cambridge Core terms of use, available at
individuals at risk of developing psychological distress. Although
it may initially increase consultation time, encouraging people
with diabetes to discuss stressful events and providing emotional
support may help to mitigate the risk of depression, the diagnosis
of which has economic implications both at the individual and
wider (health system) level. Given that stress and diabetes-related
distress are correlated, by mitigating stress, diabetes distress may
also be reduced, leading to a positive impact on the well-being
of people with diabetes. Given that PHQ-9 scores are a predictor
of MDD, early screening could prevent more severe outcomes.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S2045796020000438.
Data. The data will not be available at the present time due to it being ana-
lysed for country-specific publication in accordance with the INTERPRET-DD
investigators’ agreement.
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Table 6. Country stressors in order of importance (first six)
Argentina Death of close
family member
(141)
Major personal
injury or illness
(113)
Major change in
health of family
member (99)
Change in sleeping
habits (88)
Change in eating
habits (87)
Death of a close
friend (78)
Germany Major personal
injury or illness
(60)
Death of close
family member (46)
Change in
financial state
(21)
Major change in
health of family
member (17)
Vacation (17) Change in
responsibilities at
work (15)
India Death of close
family member
(46)
Marriage (16) Other life event/
stressor not
specified
elsewhere (14)
Religious or other
cultural festival/
activity
approaching (11)
Change in
financial state
(10)
Gain of a new family
member (10)
Italy Death of close
family member
(96)
Major change in
health of family
member (90)
Death of a close
friend (79)
Change in financial
state (74)
Major personal
injury or illness
(73)
Vacation (66)
Kenya Change in
financial state
(204)
Death of close
family member
(152)
Death of a close
friend (144)
Change in sleeping
habits (120)
Major change in
health of family
member (101)
Change in social
activities (94)
Mexico Death of close
family member
(326)
Major personal
injury or illness
(301)
Change in eating
habits (267)
Trouble with in
laws or other
family member
(136)
Major change in
health of family
member (133)
Gain of a new family
member (126)
Pakistan Change in
social activities
(60)
Change in number
of family
get-togethers (46)
Sexual
difficulties (44)
Change in number
of arguments with
spouse (40)
Change in
sleeping habits
(40)
Death of close
family member (35)
Poland Major change in
health of family
member (110)
Change in sleeping
habits (87)
Death of close
family member
(82)
Change in financial
state (71)
Change in
recreations (57)
Other life event/
stressor not
specified elsewhere
(53)
Russia Major change in
health of family
member (162)
Major personal
injury or illness
(127)
Change in
financial state
(90)
Change in sleeping
habits (77)
Death of close
family member
(56)
Change in
recreations (56)
Serbia Change in
financial state
(212)
Religious or other
cultural festival/
activity approaching
(194)
Vacation (133) Major personal
injury or illness
(127)
Major change in
health of family
member (95)
Change in
recreations (91)
Uganda Major personal
injury or illness
(68)
Sexual difficulties
(30)
Change in
sleeping habits
(29)
Change in financial
state (20)
Other life event/
stressor not
specified
elsewhere (14)
Change in eating
habits (12)
Ukraine Physical, sexual
or emotional
abuse (379)
Change in financial
state (369)
Change in
sleeping habits
(367)
Sexual difficulties
(313)
Major change in
health of family
member (310)
Change in eating
habits (301)
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DD study and the member associations of the DDD provided to the develop-
ment of the programmes included in the DDD initiative.
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